Table II.
Inflammatory markers
| Inflammatory marker | All | Bronchiectasis | Nonbronchiectasis | P |
|---|---|---|---|---|
| Biomarkers (n = 108) | ||||
| Blood eosinophils (cells × 109/L) | 0.20 (0.11-0.36) | 0.24 (0.12-0.51) | 0.19 (0.1-0.3) | .09∗ |
| Sputum eosinophils (%) | 1.5 (0.3-6.5) | 5.3 (1.5-38) | 0.8 (0.1-2.5) | .001∗ |
| Sputum neutrophils (%) | 53 (24-77) | 54 (34-75) | 52 (23-78) | .71∗ |
| IgE total (IU/mL) | 100 (19-229) | 160 (62-436) | 70 (16-207) | .006∗ |
| Feno (ppb) | 21 (12-33) | 21 (12-30) | 20 (11-34) | .75∗ |
| Eosinophil activity (n = 74) | ||||
| Degranulation (FEG 2-3) | 18 (24) | 8 (35) | 10 (20) | .16† |
| FEGs 0 | 46 (62) | 12 (52) | 34 (67) | .23† |
| FEGs 1 | 10 (14) | 3 (13) | 7 (14) | .93† |
| FEGs 2 | 14 (19) | 5 (22) | 9 (18) | .67† |
| FEGs 3 | 4 (5) | 3 (13) | 1 (2) | .05‡ |
Data are presented as n (%) or median (IQR).
FEG, Free eosinophil granule; Feno, fractional exhaled nitric oxide; IQR, interquartile range; ppb, parts per billion.
∗
Kruskal-Wallis test.
†
χ2 test.
‡
Fisher exact test.